Mild increases in plasma creatinine after intermediate to high-risk abdominal surgery are associated with long-term renal injury.


Journal

BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535

Informations de publication

Date de publication:
30 04 2021
Historique:
received: 15 10 2020
accepted: 20 04 2021
entrez: 1 5 2021
pubmed: 2 5 2021
medline: 6 1 2022
Statut: epublish

Résumé

The potential relationship between a mild acute kidney injury (AKI) observed in the immediate postoperative period after major surgery and its effect on long term renal function remains poorly defined. According to the "Kidney Disease: Improving Global Outcomes" (KDIGO) classification, a mild injury corresponds to a KIDIGO stage 1, characterized by an increase in creatinine of at least 0.3 mg/dl within a 48-h window or 1.5 to 1.9 times the baseline level within the first week post-surgery. We tested the hypothesis that patients who underwent intermediate-to high-risk abdominal surgery and developed mild AKI in the following days would be at an increased risk of long-term renal injury compared to patients with no postoperative AKI. All consecutive adult patients with a plasma creatinine value ≤1.5 mg/dl who underwent intermediate-to high-risk abdominal surgery between 2014 and 2019 and who had at least three recorded creatinine measurements (before surgery, during the first seven postoperative days, and at long-term follow up [6 months-2 years]) were included. AKI was defined using a "modified" (without urine output criteria) KDIGO classification as mild (stage 1 characterised by an increase in creatinine of > 0.3 mg/dl within 48-h or 1.5-1.9 times baseline) or moderate-to-severe (stage 2-3 characterised by increase in creatinine 2 to 3 times baseline or to ≥4.0 mg/dl). The exposure (postoperative kidney injury) and outcome (long-term renal injury) were defined and staged according to the same KDIGO initiative criteria. Development of long-term renal injury was compared in patients with and without postoperative AKI. Among the 815 patients included, 109 (13%) had postoperative AKI (81 mild and 28 moderate-to-severe). The median long-term follow-up was 360, 354 and 353 days for the three groups respectively (P = 0.2). Patients who developed mild AKI had a higher risk of long-term renal injury than those who did not (odds ratio 3.1 [95%CI 1.7-5.5]; p < 0.001). In multivariable analysis, mild postoperative AKI was independently associated with an increased risk of developing long-term renal injury (adjusted odds ratio 4.5 [95%CI 1.8-11.4]; p = 0.002). Mild AKI after intermediate-to high-risk abdominal surgery is associated with a higher risk of long-term renal injury 1 y after surgery.

Sections du résumé

BACKGROUND
The potential relationship between a mild acute kidney injury (AKI) observed in the immediate postoperative period after major surgery and its effect on long term renal function remains poorly defined. According to the "Kidney Disease: Improving Global Outcomes" (KDIGO) classification, a mild injury corresponds to a KIDIGO stage 1, characterized by an increase in creatinine of at least 0.3 mg/dl within a 48-h window or 1.5 to 1.9 times the baseline level within the first week post-surgery. We tested the hypothesis that patients who underwent intermediate-to high-risk abdominal surgery and developed mild AKI in the following days would be at an increased risk of long-term renal injury compared to patients with no postoperative AKI.
METHODS
All consecutive adult patients with a plasma creatinine value ≤1.5 mg/dl who underwent intermediate-to high-risk abdominal surgery between 2014 and 2019 and who had at least three recorded creatinine measurements (before surgery, during the first seven postoperative days, and at long-term follow up [6 months-2 years]) were included. AKI was defined using a "modified" (without urine output criteria) KDIGO classification as mild (stage 1 characterised by an increase in creatinine of > 0.3 mg/dl within 48-h or 1.5-1.9 times baseline) or moderate-to-severe (stage 2-3 characterised by increase in creatinine 2 to 3 times baseline or to ≥4.0 mg/dl). The exposure (postoperative kidney injury) and outcome (long-term renal injury) were defined and staged according to the same KDIGO initiative criteria. Development of long-term renal injury was compared in patients with and without postoperative AKI.
RESULTS
Among the 815 patients included, 109 (13%) had postoperative AKI (81 mild and 28 moderate-to-severe). The median long-term follow-up was 360, 354 and 353 days for the three groups respectively (P = 0.2). Patients who developed mild AKI had a higher risk of long-term renal injury than those who did not (odds ratio 3.1 [95%CI 1.7-5.5]; p < 0.001). In multivariable analysis, mild postoperative AKI was independently associated with an increased risk of developing long-term renal injury (adjusted odds ratio 4.5 [95%CI 1.8-11.4]; p = 0.002).
CONCLUSIONS
Mild AKI after intermediate-to high-risk abdominal surgery is associated with a higher risk of long-term renal injury 1 y after surgery.

Identifiants

pubmed: 33931017
doi: 10.1186/s12871-021-01353-2
pii: 10.1186/s12871-021-01353-2
pmc: PMC8086102
doi:

Substances chimiques

Biomarkers 0
Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

135

Références

JAMA. 2005 Aug 17;294(7):813-8
pubmed: 16106006
Ann Vasc Surg. 2016 Jan;30:72-81.e1-2
pubmed: 26187703
Intensive Care Med. 2019 Apr;45(4):407-419
pubmed: 30725141
Anesthesiology. 2020 May;132(5):1053-1061
pubmed: 31929326
Ann Thorac Surg. 2016 Nov;102(5):1482-1489
pubmed: 27319985
Anesth Analg. 2018 Nov;127(5):1236-1245
pubmed: 30138176
Crit Care. 2013 Feb 04;17(1):204
pubmed: 23394211
Crit Care. 2018 Dec 18;22(1):344
pubmed: 30563549
Anesthesiology. 2015 Sep;123(3):515-23
pubmed: 26181335
Anesthesiology. 2015 Dec;123(6):1301-11
pubmed: 26492475
J Crit Care. 2019 Apr;50:17-22
pubmed: 30469043
Anesth Analg. 2016 Jun;122(6):1912-20
pubmed: 27195635
Intensive Care Med. 2017 Jun;43(6):855-866
pubmed: 28466146
Intensive Care Med. 2016 Apr;42(4):521-530
pubmed: 26602784
PLoS One. 2016 Dec 9;11(12):e0168119
pubmed: 27936153
Crit Care. 2018 Jun 15;22(1):161
pubmed: 29907130
Eur Heart J. 2014 Sep 14;35(35):2383-431
pubmed: 25086026
PLoS One. 2017 Jul 10;12(7):e0181158
pubmed: 28700753
Eur J Anaesthesiol. 2018 Apr;35(4):273-279
pubmed: 29210843
JAMA Surg. 2016 May 1;151(5):441-50
pubmed: 26720406
Circulation. 2009 May 12;119(18):2444-53
pubmed: 19398670
J Clin Anesth. 2017 Dec;43:77-83
pubmed: 29055803
Kidney Int. 2007 Apr;71(7):679-86
pubmed: 17264879
Anaesthesia. 2020 Jan;75 Suppl 1:e121-e133
pubmed: 31903567
Anesthesiology. 2013 Sep;119(3):507-15
pubmed: 23835589
J Vasc Surg. 2018 Sep;68(3):916-928
pubmed: 30146038
Anesth Analg. 2017 Oct;125(4):1223-1232
pubmed: 28787339

Auteurs

Alexandre Joosten (A)

Department of Anesthesiology, CUB Erasme, Université Libre de Bruxelles, 808 route de Lennik, 1070, Bruxelles, Belgium. Alexandre.Joosten@erasme.ulb.ac.be.
Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Paul Brousse Hospital, Assistance Publique Hôpitaux de Paris (APHP), Université Paris-Saclay, 12 Avenue Paul Vaillant Couturier, 94800, Villejuif, France. Alexandre.Joosten@erasme.ulb.ac.be.

Brigitte Ickx (B)

Department of Anesthesiology, CUB Erasme, Université Libre de Bruxelles, 808 route de Lennik, 1070, Bruxelles, Belgium.

Zakaria Mokthari (Z)

Department of Anesthesiology, CUB Erasme, Université Libre de Bruxelles, 808 route de Lennik, 1070, Bruxelles, Belgium.

Luc Van Obbergh (L)

Department of Anesthesiology, CUB Erasme, Université Libre de Bruxelles, 808 route de Lennik, 1070, Bruxelles, Belgium.

Valerio Lucidi (V)

Department of Hepato-biliary Surgery, CUB Erasme, Université Libre de Bruxelles, 808 route de Lennik, 1070, Bruxelles, Belgium.

Vincent Collange (V)

Department of Anesthesiology, Médipole, Lyon Villeurbanne, France.

Salima Naili (S)

Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Paul Brousse Hospital, Assistance Publique Hôpitaux de Paris (APHP), Université Paris-Saclay, 12 Avenue Paul Vaillant Couturier, 94800, Villejuif, France.

Philippe Ichai (P)

Department of Liver Intensive Care Unit, AP-HP, Assistance Publique Hôpitaux de Paris, Paul-Brousse Hospital, Centre Hépato-Biliaire, 12 Avenue Paul Vaillant Couturier, 94800, Villejuif, France.

Didier Samuel (D)

Department of Liver Intensive Care Unit, AP-HP, Assistance Publique Hôpitaux de Paris, Paul-Brousse Hospital, Centre Hépato-Biliaire, 12 Avenue Paul Vaillant Couturier, 94800, Villejuif, France.

Antonio Sa Cunha (A)

Department of Hepato-biliary and Pancreatic Surgery, Assistance Publique Hôpitaux de Paris, Paul-Brousse Hospital, Centre Hépato-Biliaire, 12 Avenue Paul Vaillant Couturier, 94800, Villejuif, France.

Brenton Alexander (B)

Department of Anesthesiology, University of California San Diego, 9500 Gilman Dr, La Jolla, CA, 92093, USA.

Matthieu Legrand (M)

Department of Anesthesia and Perioperative care, University of California, San Francisco, 500 Parnassus Avenue, San Francisco, USA.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), INI-CRCT network, Paris, France.

Fabio Silvio Taccone (FS)

Department of Intensive Care, CUB Erasme, Université Libre de Bruxelles, 808 route de Lennik, 1070, Bruxelles, Belgium.

Anatole Harrois (A)

Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Bicetre Hospital, Assistance Publique Hôpitaux de Paris (APHP), Université Paris-Saclay, 78 rue du General Leclerc, 94270, Le Kremlin Bicetre, France.

Jacques Duranteau (J)

Department of Anesthesiology and Intensive Care, Hôpitaux Universitaires Paris-Sud, Université Paris-Sud, Bicetre Hospital, Assistance Publique Hôpitaux de Paris (APHP), Université Paris-Saclay, 78 rue du General Leclerc, 94270, Le Kremlin Bicetre, France.

Jean-Louis Vincent (JL)

Department of Intensive Care, CUB Erasme, Université Libre de Bruxelles, 808 route de Lennik, 1070, Bruxelles, Belgium.

Joseph Rinehart (J)

Department of Anesthesiology and Perioperative Care, University of California Irvine, 101, the City Drive South, Orange, California, USA.

Philippe Van der Linden (P)

Department of Anesthesiology, Brugmann Hospital, Université Libre de Bruxelles, 4, Place A. Van Gehuchten, 1020 Bruxelles, Bruxelles, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH